#United States #Boston #pharmaceuticals #Servier #PatientView

Servier Achieves Top Honors in 2024 PatientView Corporate Reputation Survey

In a significant achievement, Servier Pharmaceuticals has been recognized as one of the leading companies in the 2024 PatientView Corporate Reputation of Pharma survey. This annual survey gauges the perceptions and experiences of over 350 patient organizations, showcasing the company's unwavering dedication to putting patients at its core.

Overview of the Rankings

Servier's impressive recognition comes after it was also placed among the top ten pharmaceutical companies globally by PatientView. This marks a notable milestone for Servier, highlighting their commitment to enhancing patient experiences and aligning their efforts with the needs of the communities they serve.

Nicolas Garnier, Servier's Chief Patient Officer, emphasized that this recognition reflects the company's ongoing dedication to engaging with patients and their advocates. He stated, "Being recognized at the top of PatientView's annual rankings is not just an honor, it's a meaningful reflection of our continued commitment to listening to patients, collaborating closely with patient advocates, and delivering solutions that truly meet their needs."

Key Areas of Achievement

According to the survey, U.S. patient organizations ranked Servier highly in several crucial categories, including transparency of data, integrity, engagement beyond the pill, and active participation in research and development. These accolades represent Servier's efforts to foster trust and secure meaningful relationships with those it serves.

Wendy Poage, Vice President of the Patient Office at Servier, reiterated the company's stance on engaging with patient organizations and addressing their concerns regarding medicine access. "We're honored to be recognized in the PatientView report for our integrity and commitment to delivering support that goes beyond the pill," she remarked.

The Methodology Behind the Survey

The 2024 Corporate Reputation of Pharma survey took place from December 2024 through March 2025, gathering valuable insights from 372 U.S. patient groups. These groups represent over 13 million patients, providing a comprehensive overview of the pharmaceutical industry's performance as perceived by those who rely on their products and services.

Patient advocacy groups utilize this survey as a platform to review and comment on the pharmaceutical industry's effectiveness, allowing for a competitive analysis among peers. The results of this survey serve as a testament to the dedication and commitment companies invest to ensure their patient engagement strategies align with their customers' expectations.

Servier's Mission and Future Outlook

Servier is more than just a pharmaceutical company; it's a globally recognized entity driven by a non-profit foundation aimed at making a meaningful social impact. By reinvesting 100% of its profits into long-term innovations, Servier is committed not only to developing sustainable solutions but also to improving the lives of patients around the world.

A prominent leader in the treatment of hypertension and venous diseases, Servier also plays a major role in the field of cardiometabolism. The company is taking ambitious steps to become a leading player in oncology and rare cancer treatments, channeling close to 70% of its research and development budget to meet these goals.

Expanding into neurology, Servier is set to explore targeted therapies that address neurodegenerative diseases more effectively. This patient-centric approach complements their existing initiatives to provide high-quality generic medicines, ensuring affordability and accessibility of care.

In conclusion, Servier's accolades in the 2024 PatientView survey underscore a growing reputation and profound commitment to patient advocacy. The company's ethos of integrating patient feedback into their decision-making processes reflects their objective of delivering real solutions to the communities they serve. As Servier continues to find innovative approaches to medicine, its role as a leader in patient care and engagement will undoubtedly strengthen.

For more details on Servier's patient support initiatives, you can visit their official websites: servier.us/patient-support and servier.com.